| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.0002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |